Beacon Investment Advisory Services, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.29 Billion
- Q4 2024
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 3,721 shares of ALNY stock, worth $916,370. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,721
Previous 4,401
15.45%
Holding current value
$916,370
Previous $1.21 Million
27.69%
% of portfolio
0.04%
Previous 0.05%
Shares
17 transactions
Others Institutions Holding ALNY
# of Institutions
645Shares Held
109MCall Options Held
1.28MPut Options Held
1.22M-
Capital World Investors Los Angeles, CA16.5MShares$4.07 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.11 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.35 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.29 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.22 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...